Millennium Management
PRCT icon

Millennium Management’s Procept Biorobotics PRCT Stock Holding History

Millennium Management’s Portfolio PRCT Stock Details PRCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-170,000
Closed -$6.07M – 6360
2025
Q3 		$6.07M Buy
+170,000
New +$7.76M ﹤0.01% 2933
2024
Q4 		– Sell
-40,000
Closed -$3.2M – 6355
2024
Q3 		$3.2M Buy
+40,000
New +$2.84M ﹤0.01% 3240
2023
Q2 		– Sell
-10,000
Closed -$284K – 6565
2023
Q1 		$284K Buy
+10,000
New +$353K ﹤0.01% 4947

Other funds holding PRCT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $86.1B AUM 29.11% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
CC
Chicago Capital Chicago, Illinois $3.71B AUM 19.51% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Millennium Management's PRCT Position: Q1 2026 in Review

Millennium Management increased its Procept Biorobotics (PRCT) stake by 162% in Q1 2026, buying an estimated $17.5M and bringing the position to 1,005,458 shares worth $25.1M. The position accounts for 0.01% of the portfolio, ranked #1355.

Millennium Management first reported a position in PRCT in Q3 2021 and has held it in 15 quarters since. The position peaked at $31.6M in Q1 2025. 256 funds tracked by Wall St. Rank hold PRCT as of Q1 2026.

  • Millennium Management held 1,005,458 shares of Procept Biorobotics worth $25.1M as of Q1 2026.
  • Millennium Management bought 622,321 Procept Biorobotics shares in Q1 2026, an estimated $17.5M.
  • Procept Biorobotics made up 0.01% of Millennium Management's portfolio in Q1 2026, its #1355 holding.
  • Millennium Management first reported a position in Procept Biorobotics in Q3 2021 and has held it in 15 quarters since.
  • Millennium Management's Procept Biorobotics position peaked at $31.6M in Q1 2025.
  • 256 funds tracked by Wall St. Rank held Procept Biorobotics as of Q1 2026.

Based on Millennium Management's 13F filing for Q1 2026, filed 15 May 2026.